Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin vs Talc in Malignant Pleural Effusion
NCT02054078Phase 2Unknown
- Sponsor
- Tangdu Hospital
- Start
- Jan 2012
- Primary completion
- Mar 2014
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in malignant pleural effusion (MPE), sponsored by Tangdu Hospital. Status: unknown.
02
Drugs
bevacizumab
03
Conditions
malignant pleural effusion (MPE)
Beyond the preview
Go deeper on NCT02054078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02054078.